네트워크 약리학을 활용한 심상성 건선에 대한 茵蔯蒿의 잠재적 작용 기전 탐색 연구
A Network Pharmacology-based Study to Explore the Potential Mechanism of Artemisia capillaris Thunb. for Psoriasis Vulgaris
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this study is to investigate the potential mechanism of Artemisia capillaris Thunb. for psoriasis vulgaris. Methods : We conducted the network pharmacological analysis. It contains the process that search the compounds of the herb, the target proteins of the compounds, related genes of psoariasis vulgaris and the pathway/terms of the common protein lists between psoriasis vulgaris and Artemisia capillaris Thunb.. Results : 13 compounds and 30 protein targets of Artemisia Capillaris Herba were searched. And 997 psoriasis-related genes were searched. The common proteins were 11, and the core genes were 3; AKT1, CASP3, MAPK8. The related pathway/terms of 11 proteins were analyzed. ω-hydroxylase P450 pathway(60%), nitric oxide(NO) biosynthetic process(20%) were resulted. Also, 19 proteins of Artemisia Capillaris Herba were analyzed, and sterol homeostasis(78.95%), sterol biosynthetic process(15.79%), Type 2 diabetes mellitus(5.26%) were resulted. Conclusion : The Artemisia Capillaris Herba can potentially act through the ω-hydroxylase P450 pathway and nitric oxide(NO) biosynthetic process for psoriasis. Also, the metabolism of sterol biosynthesis and homeostasis can be involved in a roundabout way for psoriasis.
Abstract
Objectives : The purpose of this study is to investigate the potential mechanism of Artemisia capillaris Thunb. for psoriasis vulgaris. Methods : We conducted the network pharmacological analysis. It contains the process that search the compounds of the herb, the target proteins of the compounds, related genes of psoariasis vulgaris and the pathway/terms of the common protein lists between psoriasis vulgaris and Artemisia capillaris Thunb.. Results : 13 compounds and 30 protein targets of Artemisia Capillaris Herba were searched. And 997 psoriasis-related genes were searched. The common proteins were 11, and the core genes were 3; AKT1, CASP3, MAPK8. The related pathway/terms of 11 proteins were analyzed. ω-hydroxylase P450 pathway(60%), nitric oxide(NO) biosynthetic process(20%) were resulted. Also, 19 proteins of Artemisia Capillaris Herba were analyzed, and sterol homeostasis(78.95%), sterol biosynthetic process(15.79%), Type 2 diabetes mellitus(5.26%) were resulted. Conclusion : The Artemisia Capillaris Herba can potentially act through the ω-hydroxylase P450 pathway and nitric oxide(NO) biosynthetic process for psoriasis. Also, the metabolism of sterol biosynthesis and homeostasis can be involved in a roundabout way for psoriasis.
참고문헌 (25)
- Griffiths CEM, "Psoriasis", Lancet, 397(10281), pp.1301~1315 (2021)
- Hugh JM, "Update on the pathophysiology of psoriasis", Cutis, 102(5S), pp.6~12 (2018)
- 이주영, "인진호 추출물의 급성역류성 식도염 유발 흰쥐에 대한 개선 효과", 대한본초학회지, 31(6), pp.37~44 (2016), 대한본초학회
- Lee SY, "Therapeutic Efficacies of Artemisia capillaris Extract Cream Formulation in Imiquimod-Induced Psoriasis Models", Evid Based Complement Alternat Med, 3610494, pp.1~8 (2018)
- Hsueh TP, "The Pharmacological Effects and Pharmacokinetics of Active Compounds of Artemisia capillaris", Biomedicines, 9(10), pp.1412~ (2021)
- Luo TT, "Network Pharmacology in Research of Chinese Medicine Formula : Methodology, Application and Prospective", Chin J Integr Med, 26(1), pp.72~80 (2020)
- Ruan X, "Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking", Chin Med, 15, pp.1~17 (2020)
- 이아영, "네트워크약리학을 이용한 생강 활성성분 유래 잠재 타겟 효능 예측", 한약정보연구회지(韓藥情報硏究會誌), 8(2), pp.255~266 (2020), 한약정보연구회[DOI]
- Zhao J, "Network Pharmacology Combined with Bioinformatics to Investigate the Mechanisms and Molecular Targets of Astragalus Radix-Panax notoginseng Herb Pair on Treating Diabetic Nephropathy", Evidence-based Complement Altern Med, 9980981, pp.1~19 (2021)
- Chen H, "Quercetin ameliorates imiquimodinduced psoriasis-like skin inflammation in mice via the NF-κB pathway", Int Immunopharmacol, 48, pp.110~117 (2017)
- Yu H, "The protective effects of β-sitosterol and vermicularin from Thamnolia vermicularis (Sw.) Ach. against skin aging in vitro", An Acad Bras Cienc, 91(4), pp.1~11 (2019)
- Zhang M, "The role of PI3K", AKT, Arch Dermatol Res, pp.2019, 311(2)[DOI]
- Yue L, "PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K", Akt, Phytomedicine, pp.2019, 64(153054)[DOI]
- Bebars SMM, "Immunohistochemical Expression of Caspase-3 in Psoriasis", J Clin Diagn Res, 11(7), pp.1~5 (2017)
- Le A, "JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara®-Induced Skin Inflammation", Front Immunol, 11(604785), pp.1~14 (2021)
- Ohno Y, "Elucidation of the Synthetic Mechanism of Acylceramide, an Essential Lipid for Skin Barrier Function", Yakugaku Zasshi, 137(10), pp.1201~1208 (2017)
- Cho Yunhi, "An Inverse Relationship Between Ceramide Synthesis and Clinical Severity in Patients with Psoriasis", Journal of Korean Medical Science, 19(6), pp.859~863 (2004), 대한의학회
- Hirabayashi T, "The role of PNPLA1 in ω-O-acylceramide synthesis and skin barrier function", Biochim Biophys acta Mol cell Biol lipids, 1864(6), pp.869~879 (2019)
- Ghosh A, "Role of nitric oxide-scavenging activity of Karanjin and Pongapin in the treatment of Psoriasis", 3Biotech, 8(8), pp.1~4 (2018)
- Dilek N, "Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis", Postep dermatologii i Alergol, 33(6), pp.435~439 (2016)
- Matoshvili M, "The role of nitric oxide in the pathogenesis and severity of psoriasis", Georgian Med News, 134, pp.61~64 (2014)
- 한창이, "건선에 효과적인 한약 처방 탐색 - 지질 대사를 중심으로", 한방안이비인후피부과학회지, 34(3), pp.70~79 (2021), 대한한방안이비인후피부과학회
- Yamauchi Y, "Sterol metabolism and transport in atherosclerosis and cancer", Front Endocrinol(Lausanne), 9(509), pp.1~22 (2018)
- Varshney P, "PI3K", AKT, Biochim Biophys acta Mol basis Dis, pp.2018, 1864(5)[DOI]
- Bilia AR, "Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels", J Pharm Pharmacol, 70(7), pp.919~928 (2018)
